MedTech World is partnering with NovaX Global, a key player in connecting startups and investors, to host its first Asia roadshow of 2025 in Hong Kong on June 30 – July 1. The event will bring together MedTech leaders, investors, and innovators to explore opportunities within Asia’s growing healthcare technology landscape.
As a strategic hub in the region, Hong Kong offers MedTech companies a unique entry point into high-potential markets across Asia.
The collaboration builds on the momentum of NovaX Global Investmatch Carnival 2024, which brought together more than 10,000 attendees, 300 investors, 200 companies, and 200 media representatives—highlighting the strong appetite for innovation and meaningful connections in this space.
Why Hong Kong?
As a global MedTech hub, Hong Kong offers a powerful combination of connectivity, investment potential, and regulatory advantages:
· Global Access & Market Reach: A well-connected hub with over 70 international airlines linking 220+ destinations.
· Proximity to High-Growth Markets: Within four hours of 3.8 billion people, including direct access to China’s $1.7 trillion healthcare market.
· Thriving Innovation Ecosystem: Home to 400+ local health tech startups (2024), supported by HK$10 billion+ in government funding for biotech and healthcare innovation since 2020.
· Leading MedTech Accelerators & Global Pharma Presence: Hosts Asia’s top accelerators such as Hong Kong Science Park and Brinc, along with the global pharma headquarters such as that of Pfizer and AstraZeneca.
· Investment Powerhouse: Home to Asia’s second-largest stock market (HKEX, $4.9T market cap) and 1,500+ venture capital funds managing over $200B in assets.
· Regulatory Advantage: Fast-track MedTech approvals through Hong Kong’s MDACS system and a gateway to China’s NMPA approvals via mutual recognition agreements.
Mr. Raymond Zhao, CEO and Founder of NovaX, highlighted the collaboration will forge innovative pathways:
“On behalf of NovaX, we are honored to partner with Medtech World for the upcoming NovaX Global Investmatch Carnival 2025. This collaboration highlights our shared commitment to driving innovation and fostering meaningful connections in the MedTech ecosystem. As a leading platform connecting startups with investors, NovaX is excited to join forces with MedTech World, a pioneer in advancing healthcare technology. We aim to leverage our expertise and networks to create transformative opportunities for MedTech innovators and investors. By uniting visionary leaders, groundbreaking startups, and forward-thinking investors in Hong Kong—a gateway to Asia’s dynamic healthcare market—we are poised to redefine how innovation meets investment. Join us in NovaX Carnival and making a lasting impact on the Investmatch world. Together let’s raise fund!”
Dr. Dylan Attard, CEO and Co-Founder of MedTech World, emphasized the significance of the roadshow:
“Hong Kong is a prime destination for MedTech innovators looking to scale in Asia. Its unique combination of strong investment networks, world-class research, and progressive regulatory frameworks makes it the perfect place to drive healthcare innovation. The Hong Kong Roadshow will open doors for groundbreaking partnerships and market expansion opportunities.”
With the MedTech sector in Asia rapidly evolving, the Hong Kong Roadshow is set to be a landmark event for industry professionals seeking strategic growth opportunities.
